General Information of the Compound
| Compound ID |
CP0229143
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(S)-4-amino-5-((R)-2-boronopyrrolidin-1-yl)-5-oxopentanoic acid
Show/Hide
|
||||||||||||||||||
| Synonyms |
Non insulin dependent diabetes therapy, DARA BioSciences
Non insulin dependent diabetes therapy, Point Therapeutics
PT-630
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C9H17BN2O5
|
||||||||||||||||||
| Molecular Weight |
244.056
|
||||||||||||||||||
| Canonical SMILES |
N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1B(O)O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C9H17BN2O5/c11-6(3-4-8(13)14)9(15)12-5-1-2-7(12)10(16)17/h6-7,16-17H,1-5,11H2,(H,13,14)/t6-,7-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
DMTPQYQQHYOTQM-BQBZGAKWSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00975, Dipeptidyl peptidase 8
Protein ID: PT01238, Dipeptidyl peptidase 9
Clinical Information about the Compound